3M, Greystone enter license agreement for wound care products
ST. PAUL, Minn. 3M Health Care and Greystone Pharmaceuticals on Thursday entered into an exclusive, worldwide license agreement for wound care products using Greystone’s patented PHI technology, a proprietary formulation that aids in the management of hard-to-heal wounds.
“This license agreement will enhance 3M Health Care’s rapidly growing advanced wound care business and builds on our reputation as a global leader in the treatment of chronic wounds,” stated Bill Cruise, skin and wound care global business director, 3M Health Care. “Greystone’s innovative PHI technology is proving to be effective in managing hard-to-heal wounds, and combining this technology with our extensive global coverage will benefit patients and clinicians worldwide.”
“We have developed an innovative wound care technology that can help patients with chronic and non-responding wounds return to more active and productive lives,” stated Greg Pilant, Greystone chief executive officer. “With 3M Health Care’s global presence and deep expertise in advanced wound care, we believe we can bring valuable solutions to patients globally.”
This is the second agreement between 3M Health Care and Greystone Pharmaceuticals, the companies reported. The first agreement provided 3M Health Care limited distribution rights in Canada and parts of Europe. This new agreement broadens 3M Health Care’s rights to the United States and most major countries in the world, starting with the introduction of 3M Tegaderm Matrix Dressing with PHI technology to the U.S. market. In addition, 3M Health Care will be able to extend the PHI technology platform to other wound care products.
CHPA, CADCA applaud Senate’s abuse awareness month
WASHINGTON The Consumer Healthcare Products Association and the Community Anti-Drug Coalitions of America commended Senate Resolution 614, a resolution that designates August as National Medicine Abuse Awareness Month. Sponsored by Sens. Joseph Biden, Jr., D-Del., and Charles Grassley, R-Iowa, the designated awareness month would help spawn community involvement and participation in efforts to educate parents about the dangers of medicine abuse among teens.
“Consumers have trusted the makers of over-the-counter medications with the health of their families for many years,” stated CHPA president Linda Suydam. “National Medicine Abuse Awareness Month presents a timely opportunity to build community awareness and alert parents and teens that abusing medicine to get a high is very dangerous.”
In recognition of the designation, CHPA and CADCA will be hosting town hall meetings nationwide with local anti-drug abuse advocates, substance abuse treatment experts, healthcare professionals, and policy makers, the two organizations announced.
“While surveys show that overall illicit drug use among youth is on a downward trend, unfortunately the rates of over-the-counter and prescription drug abuse are holding steady,” noted Arthur Dean, CADCA chairman and chief executive officer. “Designating August as National Medicine Abuse Awareness Month will help bring this issue to the radar screen, and I hope community organizations take advantage of this opportunity to raise awareness about this dangerous trend.”
Town hall meetings are already scheduled during August in Seattle; San Antonio, Texas; and Miami. This designation, if passed into law, would mark the second annual National Medicine Abuse Awareness Month. In all, CHPA and CADCA have hosted a total of 13 town hall meetings nationwide since August 2007.
Glucose control snack crisps get expanded distribution
ST. LOUIS ExtendSnacks recently announced expanded distribution of its ExtendCrisps, a crunchy snack using a patented formulation of uncooked cornstarch to help provide up to 9 hours of glucose control.
First launched in January, these all-natural crisps retail for a suggested $1.59 for a snack-size bag and are available in five flavors—white cheddar, Italian herb, honey BBQ, cinnamon and zesty ranch.